HACE1 and cancer: Numerous cancer patient-derived mutations in HACE1 (Gln173 (analyzed here; Fig. 6c), Ile71, Ile132, Arg143, Asp161, Gly175 and Arg547 (ref. 76)) coincide with the RAC1 binding site and may alter its properties.